LINC00528, a gene that emerges as a key protecting player in tumor progression (Gong et al., 2020; Zhang et al., 2021), has demonstrated its potential in impeding cancer development by inducing programmed cell death and restraining cellular proliferation under laboratory conditions (Liu et al., 2020). The gene discussed is LINC00528; the disease is neoplasm.